Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
symbol logo$EW Q4 '24 Earnings Results & Recap Edwards Lifesciences Corp. reported Q4 2024 EPS of $0.59, exceeding the estimate of $0.55, and revenue of $1.39B, exceeding the estimate of $1.36B; however, Q1 2025 guidance suggests a potential deceleration in growth.
4

Since Post

Full Details

Advertisement|Remove ads.